Markers of microvascular complications in insulin dependent diabetes

Archives of Disease in Childhood

Volumn 87, Issue 1, 2002, Pages 10-12

  Schultz, C J ^a   Amin, R ^a   Dunger, D B ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; DISEASE MARKER; ENDOCRINE SYSTEM; GENETIC RISK; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICROALBUMINURIA; MICROVASCULATURE; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SCREENING; SEX DIFFERENCE; SHORT SURVEY; VASCULAR DISEASE;

ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MASS SCREENING; MICROCIRCULATION; PHENOTYPE; PUBERTY; RISK FACTORS;

EID: 0036315156     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.87.1.10     Document Type: Short Survey

References (28)

1. Microalbuminuria prevalence varies with age, sex and puberty in children with insulin dependent diabetes followed in a longitudinal study from diagnosis
2. Prevalence and development of retinopathy in children and adolescents with type-1 (insulin dependent) diabetes mellitus. A longitudinal study
3. Enhanced progression of urinary albumin excretion in IDDM during puberty
4. Microalbuminuria is not rare before 5 years of IDDM
5. Progression of borderline increases in albuminuria in adolescents with insulin-dependent diabetes mellitus
6. A 3-19 year follow-up study on diabetic retinopathy in patients diagnosed in childhood and treated with conventional therapy
7. Prevalence of diabetic retinopathy in children and adolescents with IDDM. A population-based multicentre study
8. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type I (insulin-dependent) diabetes mellitus
9. Freezing method affects the concentration and variability of urine proteins and the interpretation of data on microalbuminuria
10. Risk of nephropathy can be detected before the onset of microalbuminuria during the early years from diagnosis of type-1 diabetes mellitus
11. Enhanced progression of urinary albumin excretion in IDDM during puberty
12. Long-term glycaemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes
13. Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type-1 diabetes mellitus
14. Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients
15. The progression of retinopathy over 2 years: The Pittsburg epidemiology of diabetes complications (EDC) study
16. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial
17. Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: The EURODIAB IDDM Complications Study
18. The impact of a family history of type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with type I (insulin-dependent) diabetes mellitus
19. Familial and perinatal risk factors for micro- and macroalbuminuria in young IDDM patients
20. Genetics of diabetic nephropathy
21. Indications of low sex hormone binding globulin (SHBG) in young females with type 1 diabetes, and an independent association to microalbuminuria
22. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
23. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial
24. Effects of ramipril on cardiovascular and microavascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
25. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
26. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus
27. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type I (insulin-dependent) diabetes mellitus